Fellowship · Hartford, CT
Sponsored by University of Connecticut School of Medicine · Director Katherine Baldwin
Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives.
Gastroenterology · 2023 · 171 citations · Jeffrey Hyams
Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course.
Cell host & microbe · 2024 · 65 citations · Jeffrey Hyams
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
The lancet. Gastroenterology & hepatology · 2023 · 57 citations · Jeffrey Hyams
Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
The lancet. Gastroenterology & hepatology · 2024 · 24 citations · Jeffrey Hyams
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease.
Gastroenterology · 2025 · 22 citations · Jeffrey Hyams
Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease.
Clinical pharmacology and therapeutics · 2021 · 70 citations · Jeffrey Hyams
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World Data.
Therapeutic drug monitoring · 2026 · 6 citations · Jeffrey Hyams
Environmental Factors Associated With Risk of Crohn's Disease Development in the Crohn's and Colitis Canada - Genetic, Environmental, Microbial Project.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024 · 29 citations · Jeffrey Hyams